4-amino-6-methyl-2-(3-(4-p-tolylpiperazin-1-yl)propyl)-5-vinylpyridazin-3(2H)-one

ID: ALA584606

PubChem CID: 44596863

Max Phase: Preclinical

Molecular Formula: C21H29N5O

Molecular Weight: 367.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N

Standard InChI:  InChI=1S/C21H29N5O/c1-4-19-17(3)23-26(21(27)20(19)22)11-5-10-24-12-14-25(15-13-24)18-8-6-16(2)7-9-18/h4,6-9H,1,5,10-15,22H2,2-3H3

Standard InChI Key:  SSHKNPUBWWFZGC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -4.0583   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0583   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3463   -3.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6343   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6343   -2.2417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3463   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7740   -1.8313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9204   -3.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3463   -4.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7722   -3.4802    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6318   -4.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3463   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6318   -0.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6318    0.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9174    0.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2027    0.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4903    0.6450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4861    1.4703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2004    1.8850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9190    1.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2296    1.8777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9428    1.4608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6583    1.8699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6619    2.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440    3.1109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2314    2.6994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3774    3.1065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  0
  1  7  2  0
 14 15  1  0
 15 16  1  0
  1  2  1  0
  4  8  1  0
  1  6  1  0
  3  9  1  0
  2  3  2  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  2 10  1  0
  3  4  1  0
 21 22  2  0
  9 11  2  0
 22 23  1  0
  4  5  2  0
 23 24  2  0
  6 12  1  0
 24 25  1  0
  5  6  1  0
 25 26  2  0
 26 21  1  0
 18 21  1  0
 12 13  1  0
 24 27  1  0
M  END

Associated Targets(Human)

ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 367.50Molecular Weight (Monoisotopic): 367.2372AlogP: 2.30#Rotatable Bonds: 6
Polar Surface Area: 67.39Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.88CX LogP: 1.91CX LogD: 1.31
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.85Np Likeness Score: -1.50

References

1. Biancalani C, Giovannoni MP, Pieretti S, Cesari N, Graziano A, Vergelli C, Cilibrizzi A, Di Gianuario A, Colucci M, Mangano G, Garrone B, Polenzani L, Dal Piaz V..  (2009)  Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain.,  52  (23): [PMID:19788200] [10.1021/jm900458r]
2. Vergelli C, Ciciani G, Cilibrizzi A, Crocetti L, Di Cesare Mannelli L, Ghelardini C, Guerrini G, Iacovone A, Giovannoni MP..  (2015)  Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents.,  23  (19): [PMID:26361735] [10.1016/j.bmc.2015.08.043]

Source